Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The primary outcome is to identify the maximum dose tolerated, and the second aim is to evaluate neurological outcome
Ketharnathan, S
Due to risks for decreased bioavailability of birth control pills, the manufacturer of Mounjaro (tirzepatide) recommends that patients either use barrier contraception for four weeks after initiation or dosage increase or switch to a non-oral contraceptive
More Information
0% of patients receiving placebo
This may increase the risk of residual gastric contents despite preoperative fasting
US$ 22.59
US$ 29.06
US$ 28.77
US$ 27.02
US$ 20.71
